Abstract. Ischemic heart disease is a major health threat, resulting in a large number of mortalities annually worldwide. Oxidative stress is one of the main causes of cell death during ischemia-reperfusion (IR) injury. Cyclin dependent kinase inhibitor 1A (known as p21) is important in protecting tissues against IR injury, however the mechanism remains unknown. In the present study, oxygen-glucose deprivation and subsequent reoxygenation (OGD/R) in H9c2 heart-derived myocytes was used as a model to study myocardial IR injury in vitro. mRNA and protein expression levels were determined by reverse transcription-quantitative polymerase chain reaction and western blotting, respectively. The levels of reactive oxygen species were measured using the fluorescence dye 2',7'-dichlorodihydrofluorescein diacetate. The present data demonstrated that p21 expression was upregulated by tumor protein p53 (p53) in H9c2 cells exposed to OGD/R. p21 protected H9c2 cells against OGD/R-induced oxidative stress. In addition, p21 mediated upregulation of NF-E2-related factor-2 (Nrf2), a regulator of antioxidant responses, which in turn suppressed cell death in H9c2 cells subjected to OGD/R. Thus, activation of the p53/p21/Nrf2 signaling pathway may be an important adaptive response that limits oxidative injury during IR.
Introduction
Ischemia-reperfusion (IR) injury occurs when blood flow to an organ is disrupted and subsequently re-introduced, and it is associated with a variety of diseases, including myocardial infarction, shock liver, and acute ischemic renal failure (1) (2) (3) . Ischemic and reperfusion conditions lead to ATP depletion, accumulation of toxic metabolites, such as reactive oxygen species (ROS), and initiation of apoptotic and necrotic cascades in the affected organs (4, 5) . The molecular mechanism by which cells and tissues adapt to IR involves the upregulation of cytoprotective genes that maintain cellular homeostasis. For instance, expression of the anti-apoptotic protein Bax inhibitor-1 (BI-1) is induced during IR injury, and bi-1-/-mice exhibit increased sensitivity to renal IR injury, suggesting that bi-1 gene induction is needed to protect tissues (5) .
Cyclin dependent kinase inhibitor 1A (termed p21) is important in cell cycle regulation (6) . Previously, Megyesi et al (7) have demonstrated that expression of p21 is significantly upregulated following renal ischemia. In p21-/-mice, renal function is more impaired and overall mortality is significantly increased compared with wild-type mice following renal ischemia, suggesting a protective role of p21 in ischemic acute renal failure. p21 has also been demonstrated to be involved in recovery from hepatic IR injury (8) . However, the molecular mechanisms by which p21 exerts its protective effect on IR injury are not fully understood.
Oxidative stress is a major causes of cell death during IR injury (1) . p21 protects cells against oxidative stress by upregulating the ER-resident chaperone heat shock protein family A (HSPA5, also known as BIP and GRP78) and suppressing endoplasmic reticulum stress (9) . Chen et al (10) reported that the antioxidant function of p21 is mediated through stabilizing NF-E2-related factor-2 (Nrf2), a transcription factor that regulates expression of various detoxification and antioxidant enzymes (11) . Given the importance of oxidative stress in IR injury, the present study aimed to investigate whether p21 protects cardiomyocytes against IR injury by suppressing oxidative stress. 
Materials and methods

Cell
Oxygen-glucose deprivation/reoxygenation (OGD/R).
Cells were subjected to OGD/R as previously described (12), with minor modifications. When cells reached 60-80% confluency, they were washed with PBS and cultured in glucose-free, serum-free DMEM medium in an anoxia chamber (94% N 2 /5% CO 2 /1% O 2 ) for 4 h, then cultured in high glucose (4,500 mg/l) DMEM medium containing 10% FBS in a normal cell incubator (95% air/5% CO 2 ) for an additional 12 h. To test the role of p53 in p21 expression, cells were pre-incubated with 30 µM p53 inhibitor pifithrin-α (Sigma-Aldrich; Merck Millipore, Darmstadt, Germany) for 30 min.
Cell viability assay. Cell survival was measured using the Reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Total RNA was isolated using TRIzol reagent (Thermo Fisher Scientific, Inc.). Random-primed cDNAs were generated by reverse transcription of total RNA samples with SuperScript II, as per the manufacturer's instructions (Thermo Fisher Scientific, Inc.). qPCR was performed using the SYBR Premix Ex Taq kit (Takara Biotechnology, Co., Ltd., Dalian, China) on a LightCycler 480 system (Roche Applied Science, Penzberg, Germany), as per the manufacturer's instructions. The cycle number at which the reaction crossed an arbitrarily placed threshold (CT) was determined for each gene, and the relative amount of each mRNA to mRNA of β-actin was described using the 2 -∆∆Cq method (13) . The primers used for qPCR were as follows: p21 forward, 5'-TCT GCT GCT CTC CCT TCC T-3' and reverse, 5'-CAC CAC CAC CAC ATA CCA C-3'; tumor protein p53 (p53) forward, 5'-CCC ATC CTT ACC ATC ATC ACG-3' and reverse, 5'-CAG GCA CAA ACA CGA ACC T-3'; Nrf2 forward, 5'-CCC AGC ACA TCC AGA CAG AC-3' and reverse 5'-TCC AGG GCA AGC GAC TCA T-3'; NAD (P)H quinone oxidoreductase 1 (NQO1) forward, 5'-GAA GAA AGG ATG GGA GGT GGT-3' and reverse, 5'-GGT GGT GAT GGA AAG CAA GG-3'; heme oxygenase-1 (HO-1) forward, 5'-GCG AAA CAA GCA GAA CCC A-3' and reverse, 5'-GGC TGG TGT GTA AGG GAT GG-3'; β-actin forward, 5'-GAT GGT CTT GGT TTC TGT GCC-3' and reverse, 5'-TGC TGT TTC CGC CTT CTG G-3' .
Western blotting. Cells were lysed on ice for 30 min in lysis buffer (BioTeke Corporation, Beijing, China). The lysates were centrifuged at 14,000 x g for 15 min at 4˚C, and the supernatants were collected. The protein concentration was determined by a Bradford protein assay kit (BioTeke Corporation). Total cell lysates (30 µg) were separated on a 10% SDS-polyacrylamide gel. Proteins were then transferred to polyvinylidene fluoride membranes. Membranes were blocked for non-specific binding with 5% bovine serum albumin in Tris phosphate buffered saline (TPBS) at room temperature for 30 min, following which they were incubated overnight at 4˚C with primary antibodies. Primary antibodies were as follows: Anti-β-actin (cat. no. A2066; 1:1,000 dilution; Sigma-Aldrich; Merck Millipore), anti-p21 (cat. no. sc-817; 1:500 dilution; Santa Cruz Biotechnology, Inc. Dallas, TX, USA), anti-p53 (cat. no. sc-126; 1:1,000 dilution; Santa Cruz Biotechnology, Inc.) and anti-Nrf2 (cat. no. sc-722; 1:500 dilution; Santa Cruz Biotechnology, Inc.). Membranes were subsequently washed with TPBS three times, and incubated with horseradish peroxidase-conjugated anti-rabbit or -mouse immunoglobin G secondary antibodies [cat. nos. M21002 and H20704 respectively; 1:5,000 dilution; Abmart (Shanghai) Co., Ltd., Shanghai, China] for 1 h at room temperature. Following three washes with TPBS, membranes were exposed to Amersham Hyperfilm Enhanced Chemiluminescence (GE Healthcare Bio-Sciences, Pittsburgh, PA, USA). Following this, membranes were exposed to Kodak X-OMAT film (Kodak, Rochester, NY, USA) and the films developed.
RNA interference.
To knockdown the expression of p21 and Nrf2 by RNA interference, H9c2 cells were transfected at 50% confluence with 100 nM of p21 or Nrf2-specific small interfering RNA (siRNA; GenePharma Co., Ltd., Shanghai, China) in Opti-MEM medium (Thermo Fisher Scientific, Inc.) using Lipofectamine 2000 transfection agent (Thermo Fisher Scientific, Inc.), as per the manufacturer's instructions. Gene silencing efficiency was determined by RT-qPCR and western blotting 72 h post-transfection. A non-specific siRNA sequence was used as a negative control. Endogenous p21 and Nrf2 mRNA and protein expression levels were significantly ablated by siRNA in H9c2 cells compared with the negative control siRNA (Fig. 1) . siRNA sequences were as follows (sense strand): p21, 5'-UCC AAU UCC CCU UAA CUC GGG-3'; Nrf2, 5'-UUG UUU UCC GUA UUA AGA CA-3', and negative control 5'-UUC UCC GAA CGU GUC ACG UTT-3'.
Statistical analysis. Data were expressed as the mean ± standard deviation. Statistical differences between groups were analyzed using one-way analysis of variance, followed by a Student-Newman-Keuls test. P<0.05 was considered to indicate a statistically significant difference.
Results
OGD/R induces cell death through ROS.
In the present study, OGD/R in H9c2 heart-derived myocytes was used as an in vitro model to study IR. A significant increase in cell death was detected by MTS assay in OGD/R-treated H9c2 cells compared with untreated cells (Fig. 2A) . Oxidative stress has been demonstrated to be important in acute myocardial infarction (1, 14) . Therefore, ROS levels were assessed in OGD/R-treated H9c2 cells using an H 2 DCF-DA probe. The results demonstrated that OGD/R induced a 4-fold increase in ROS levels in H9c2 cells, compared with the untreated cells (Fig. 2B) . To investigate whether cell death in OGD/R-treated cells was mediated by ROS, the experiment was repeated in the presence of two antioxidants, glutathione ethyl ester (GEE) and N-acetylcysteine (NAC). Both GEE and NAC significantly reduced cell death ROS production in OGD/R-treated H9c2 cells, compared with cells that received no antioxidant treatment ( Fig. 2A and B , Figure 1 . Knockdown of endogenous p21 and Nrf2 expression in H9c2 cells using siRNA. Cells were transfected with specific siRNAs to (A) p21 and (B) Nrf2, and efficiency of gene silencing was determined by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and western blotting (with β-actin used as a reference gene and loading control, respectively). For RT-qPCR, data are expressed as mean ± standard deviation of three independent experiments. For western blotting, the blot is representative of three experiments. A non-specific siRNA sequence was used as negative control. NC, negative control; p21, cyclin dependent kinase inhibitor 1A; siRNA, small interfering RNA; Nrf2, NF-E2-related factor-2. respectively). The present results further confirm that ROS is important in OGD/R-induced cell death in cardiomyocytes.
p21 prevents OGD/R-induced cell death. p21 expression is often upregulated during IR injury (8, 15) . In the present study, mRNA and protein expression levels of p21 were demonstrated to be significantly increased in OGD/R-treated H9c2 cells, compared with untreated cells (Fig. 3A) . To address whether this induction of p21 expression is required for cell survival, p21 expression was silenced using siRNA. The results demonstrated that knockdown of p21 significantly promoted cell death and increased ROS production in OGD/R-treated H9c2 cells, compared with OGD/R-treated cells transfected with control siRNA (Fig. 3B) .
Upregulation of p21 is mediated by p53. As p21 is a target gene of p53, whether induction of p21 in OGD/R-treated cells may be dependent on p53 was investigated. Initially, the effect of OGD/R treatment on p53 expression was examined. The results demonstrated that OGD/R treatment in H9c2 cells markedly increased the protein expression levels of p53, whereas the mRNA expression levels were not significantly different from untreated cells (Fig. 4A) . Subsequently, the effect of the p53 inhibitor pifithrin-α (16) on p21 expression was examined. The results demonstrated that p53 inhibition significantly decreased the OGD/R-induced expression of p21 in H9c2 cells, at the protein and the mRNA level (Fig. 4B) . These data indicate that p53 is involved in the upregulation of p21 following OGD/R.
Nrf2 is required for survival following OGD/R.
Transcription factor Nrf2 is a regulator of cell antioxidant responses, and it is elevated in IR injury (4) . Therefore, expression of Nrf2 was examined following OGD/R treatment in H9c2 cells. As demonstrated in Fig. 5A , OGD/R treatment increased Nrf2 protein expression levels, but the mRNA levels were not changed, compared with untreated cells. These data suggest that Nrf2 may be important in the cellular defense against OGD/R-induced cell death. Indeed, knockdown of Nrf2 by siRNA significantly reduced cell death and increased ROS production in OGD/R-treated H9c2 cells compared with OGD/R-treated cells transfected with control siRNA (Fig. 5B) .
OGD/R induced Nrf2-regulated antioxidant gene expression via p21.
Previous studies have demonstrated that p21 may stabilize Nrf2 by inhibiting its degradation (10) , raising the hypothesis that OGD/R-induced Nrf2 protein upregulation may be mediated by p21. To test this hypothesis, endogenous p21 expression was silenced by siRNA in H9c2 cells. Knockdown of p21 resulted in markedly reduced protein expression levels of Nrf2 in OGD/R-treated H9c2 cells compared with OGD/R-treated cells transfected with control siRNA (Fig. 6A ). In addition, the mRNA expression levels of two known oxidative stress markers, and gene targets of Nrf2 (NQO1 and HO-1) were examined. As expected, the mRNA expression levels of NQO1 and HO-1 were significantly upregulated following OFD/R treatment in H9c2 cells compared with untreated cells (Fig. 6B) . However, this effect was significantly attenuated in p21 silenced OFD/R-treated cells, compared to OFD/R-treated cells transfected with a control siRNA (Fig. 6B) . Taken together, these results indicate that p21 is important in activating the Nrf2-mediated antioxidant response following OGD/R.
Discussion
Myocardial apoptosis is critical in the pathogenesis of acute myocardial infarction and heart failure (17) . Oxidative stress is one of the main causes of myocardial apoptosis following heart IR damage (14) . The present study demonstrated that the p53/p21/Nrf2 pathway protects against OGD/R-induced H9c2 cell death by suppressing ROS production. Thus, induction of the p53/p21/Nrf2 pathway may represent an important adaptive cell response to limit oxidative injury during IR.
The mechanism underlying the upregulation of p21 during IR injury remains controversial. p21 expression is significantly elevated in the liver of mice that are subjected to hepatic IR injury, through activation of p53, a known regulator of p21 (8) . However, Yoshida et al (15) demonstrated that the expression of activating transcription factor 3 (ATF3) is significantly increased in the kidney of a mouse model of IR injury. Overexpression of ATF3 leads to upregulation of p21 and downregulation of p53 in human kidney-2 cells subjected to oxidative stress (15) , suggesting that p21 may be a downstream target of ATF3, rather than p53, during IR injury. In the present study, it was demonstrated that p53 inhibition suppressed the p21 expression, indicating that OGD/R-induced p21 upregulation is p53-dependent. Notably, p53 protein levels, rather than mRNA levels, were upregulated in H9c2 cells following OGD/R. Thus, post-transcriptional regulation may be a key process in the control of p53 expression. A recent study has revealed that OGD/R significantly inhibits the phosphorylation of AKT serine/threonine kinase 1 (Akt) in H9c2 cells (18) . It is well established that Akt phosphorylates the E3 ubiquitin ligase MDM2 proto-oncogene, enhancing MDM2-mediated degradation of p53 by ubiquitination (19) . It is very likely therefore that inactivation of Akt may lead to accumulation of p53 protein following OGD/R, due to decreased MDM2-mediated degradation. Further studies will be required to clarify this hypothesis.
The transcription factor Nrf2A is a master regulator of phase-II detoxification enzymes and antioxidant genes through binding with antioxidant response elements within the promoters of these genes (20, 21) . Previous studies have demonstrated that IR induces Nrf2 expression or upregulates Nrf2-dependent gene expression in liver and kidney (4, 22) . Furthermore, serum urea nitrogen levels in Nrf2-null mice are higher than those in wild-type mice following IR (22) . These data suggest that Nrf2 is a crucial molecule for the coordinated cytoprotective response to oxidative stress during IR. In the present study, it was demonstrated that the upregulation of Nrf2 expression by OGD/R was mediated by p21 in cardiomyocytes. Under basal conditions, an E3 ubiquitin ligase, kelch like ECH associated protein 1 (Keap1), targets Nrf2 for ubiquitination-mediated degradation (23) . Notably, a previous study has demonstrated that p21 can directly interact with Nrf2 and thus competes with Keap1 for Nrf2 binding, suppressing ubiquitination of Nrf2 (10) . Thus, the OGD/R-induced upregulation of Nrf2 via p21 observed in the present study, may be explained by this previously reported p21 capacity to stabilize Nrf2 and suppress its ubiquitination and degradation.
In summary, the present study demonstrated that upregulation of p21 following OGD/R was p53-dependent. p21 protected cardiomyocytes from IR injury by suppressing oxidative stress, in part through Nrf2, a master regulator of antioxidant responses. These findings provided valuable insights into the p53/p21/Nrf2 signaling in ischemic heart disease. Further in vivo investigations will be required in the future to fully comprehend the role of this pathway in IR-damaged cardiomyocytes. . OGD/R, oxygen-glucose deprivation/reoxygenation; NC, negative control siRNA; p21, cyclin dependent kinase inhibitor 1A; siRNA, small interfering RNA; Nrf2, NF-E2-related factor-2; NQO1, NAD(P)H quinone oxidoreductase 1; HO-1, heme oxygenase-1.
